Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
detroit blog main
4
×
detroit top stories
drugs
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
fda
indiana blog main
indiana top stories
investing
national
abbvie
astrazeneca
bristol-myers squibb
cancer immunotherapy
cystic fibrosis
eli lilly
What
bio
roundup
companies
drug
fda
admits
ago
ahead
alzheimer’s
annual
approved
asco
assessed
attention
big
biotech
biotechs
branded
choices
classes
combinator
commissioner
communities
conference
consumers
costly
counterweight
digital
disease
drugs
dug
elevatebio
epidemic
esmo
europe
fatty
frenzied
generic
germany
graft
Language
unset
Current search:
drugs
×
startups
×
" detroit blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
